title: [Principles of radiotherapy of non-small cell lung cancer].
abstract: The long-term survival probability for Hungarian lung cancer patients is 10% worse than the best results published in the most highly developed countries (the mean 5-year survival probability in Hungary is 5%, in contrast with the 15% survival probability in the USA). On the basis of the international recommendations and personal experience, an attempt was made to formulate the guidelines for radiotherapy as one of the fundamental non-small cell lung cancer (NSCLC) treatment modalities for national use. An expert panel was set up comprising physicians from 6 radiotherapeutic centers (the National Institute of Oncology / Semmelweis University, Budapest; the Beth Israel Medical Center, New York; the University of Kaposvár; the University of Essen; the University of Debrecen; and the County Hospital of Gyula). Experts in two important medical fields closely related to radiotherapy (surgery and diagnostic imaging) were also engaged in the elaboration of the manuscript. Discussion of the most important principles of the radiotherapy and an overview of the prognostic factors was followed by a critical analysis of the protocols applied in the radiotherapy of Hungarian NSCLC patients during recent decades. The new guidelines suggested for the radiotherapy of NSCLC are presented separately for the postoperative period, marginally resectable tumors, and the aggressive or non-aggressive radiotherapy of inoperable tumors. Detailed accounts are given of the techniques of external irradiation and brachytherapy, and of the acute and late radiation-induced damage of normal tissues. The authors believe that this document may be instrumental in improving the survival index of Hungarian NSCLC patients in the near future.
authors.affiliation: Sugárterápiás Osztály, Országos Onkológiai Intézet, Budapest, Hungary. esik@oncol.hu
authors.forename: Olga
authors.initials: O
authors.lastname: Esik
authors.forename: Akos
authors.initials: A
authors.lastname: Horváth
authors.forename: András
authors.initials: A
authors.lastname: Bajcsay
authors.forename: Katalin
authors.initials: K
authors.lastname: Hideghéty
authors.forename: László
authors.initials: L
authors.lastname: Agócs
authors.forename: Béla
authors.initials: B
authors.lastname: Pikó
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Lengyel
authors.forename: Agota
authors.initials: A
authors.lastname: Petrányi
authors.forename: Julianna
authors.initials: J
authors.lastname: Pisch
mesh_terms: D001918:Brachytherapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D019583:Dose Fractionation, Radiation; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D011832:Radiation Injuries / Q000209:etiology* / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D011879:Radiotherapy Dosage; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D015996:Survival Rate
vernacular_title: A nem kissejtes tüdôrák sugárterápiájának irányelvei.